World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
78
Citations
28710
World Ranking
1254
National Ranking
556

Medicine

D-Index
81
Citations
30053
World Ranking
16464
National Ranking
8277

Kent A. Sepkowitz publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Kent A. Sepkowitz sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 251 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Kent A. Sepkowitz D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Kent A. Sepkowitz sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 78 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Kent A. Sepkowitz is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research predominantly focuses on the intersection of oncology and infectious diseases, with a particular emphasis on the effects of COVID-19 among cancer patients.

Their recent publications include studies on COVID-19 severity and infectiousness within immunocompromised populations. Notable papers are:

  • Determinants of COVID-19 disease severity in patients with cancer, 2020, Nature Medicine
  • Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer, 2020, New England Journal of Medicine
  • Determinants of Severity in Cancer Patients with COVID-19 Illness, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Institutional quality and patient safety programs: An overview for the healthcare epidemiologist, 2020, Infection Control and Hospital Epidemiology
  • Improving Urinary Tract Infection Diagnostics in Oncology: Reliability of Reflex Urine Culture in Immunosuppressed Neutropenic and Non-neutropenic Cancer Patients, 2025, Clinical Infectious Diseases

Frequent co-authors in their collaborative work include Mini Kamboj, N. Esther Babady, Anabella Lucca Bianchi, Genovefa A. Papanicolaou, and Tobias M. Hohl. These collaborations often contribute to research situated at the interface of cancer care and infectious disease management.

The primary venues for publication are Clinical Infectious Diseases and Infection Control and Hospital Epidemiology, each featuring multiple works. Other journals include Nature Medicine, New England Journal of Medicine, and bioRxiv.

Kent A. Sepkowitz's main field of study is Medicine, with specific focus areas including:

  • Oncology
  • Epidemiology
  • Infectious Diseases
  • General Health Professions
  • Pulmonary and Respiratory Medicine

Their research topics cover various aspects of healthcare impact due to COVID-19, clinical studies related to COVID-19, and infection control. Key research themes include:

  • COVID-19 and healthcare impacts
  • COVID-19 Clinical Research Studies
  • Healthcare cost, quality, practices
  • Infection Control and Ventilation
  • Long-Term Effects of COVID-19
  • Bacterial Identification and Susceptibility Testing
  • Neutropenia and Cancer Infections

Best Publications

  • Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

    Alison G. Freifeld;Eric J. Bow;Kent A. Sepkowitz;Michael J. Boeckh

  • Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

    Marcie Tomblyn;Tom Chiller;Hermann Einsele;Ronald Gress

  • Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

    M. Tomblyn;T. Chiller;H. Einsele;R. Gress

  • Effect of Daily Chlorhexidine Bathing on Hospital-Acquired Infection

    Michael W. Climo;Michael W. Climo;Deborah S. Yokoe;David K. Warren;Trish M. Perl

  • Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

    Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston

  • Determinants of COVID-19 disease severity in patients with cancer.

    Elizabeth V. Robilotti;Elizabeth V. Robilotti;N. Esther Babady;Peter A. Mead;Peter A. Mead;Thierry Rolling

  • Opportunistic Infections in Patients with and Patients without Acquired Immunodeficiency Syndrome

    Kent A. Sepkowitz

  • AIDS — The First 20 Years

    Kent A. Sepkowitz

  • Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

    Alison G. Freifeld;Eric J. Bow;Kent A. Sepkowitz;Michael J. Boeckh

  • Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit.

    Cassandra D. Salgado;Kent A. Sepkowitz;Joseph F. John;J. Robert Cantey

  • Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.

    Teresa Aydillo;Ana S Gonzalez-Reiche;Sadaf Aslam;Adriana van de Guchte

  • The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial.

    Michael W. Climo;Kent A. Sepkowitz;Gianna Zuccotti;Victoria J. Fraser

  • Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital.

    Kent A. Sepkowitz;Arthur E. Brown;Edward E. Telzak;Scott Gottlieb

  • Adverse outcomes associated with contact precautions: A review of the literature

    Daniel J. Morgan;Daniel J. Diekema;Kent Sepkowitz;Eli N. Perencevich

  • Multidrug-Resistant Tuberculosis in Patients without HIV Infection

    Edward E. Telzak;Kent Sepkowitz;Peter Alpert;Sharon B. Mannheimer

  • Selective CD4+ Lymphopenia in Melanoma Patients Treated With Temozolomide: A Toxicity With Therapeutic Implications

    Y.B. Su;Sejean Sohn;Susan E. Krown;Philip O. Livingston

  • Nosocomial infections in patients with cancer

    Mini Kamboj;Kent A Sepkowitz

  • Complication Rates Among Cancer Patients With Peripherally Inserted Central Catheters

    Louise J. Walshe;Sharp F. Malak;Janet Eagan;Kent A. Sepkowitz

  • Occupationally Acquired Infections in Health Care Workers: Part II

    Kent A. Sepkowitz

  • Why don't physicians test for HIV? A review of the US literature.

    Ryan C Burke;Kent A Sepkowitz;Kyle T Bernstein;Adam M Karpati

Frequent Co-Authors

Timothy E. Kiehn
Timothy E. Kiehn Memorial Sloan Kettering Cancer Center
Eric G. Pamer
Eric G. Pamer Memorial Sloan Kettering Cancer Center
Ying Taur
Ying Taur Memorial Sloan Kettering Cancer Center
Trish M. Perl
Trish M. Perl The University of Texas Southwestern Medical Center
Donald Armstrong
Donald Armstrong Memorial Sloan Kettering Cancer Center
Michael Boeckh
Michael Boeckh Fred Hutchinson Cancer Research Center
Daniel J. Diekema
Daniel J. Diekema University of Iowa Hospitals and Clinics
Douglas A. Jabs
Douglas A. Jabs Johns Hopkins University School of Medicine
Michael S. Glickman
Michael S. Glickman Memorial Sloan Kettering Cancer Center
Victoria J. Fraser
Victoria J. Fraser Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology can open doors to diverse career options beyond traditional lab roles. For those seeking flexible learning options, several online colleges that accept felons offer programs in related health and science fields, ensuring education is accessible to many.

One exciting pathway is becoming a functional medicine nurse practitioner. This role combines holistic approaches with scientific knowledge, which can complement a background in microbiology, especially when focusing on infection and immunity.

For those interested in healthcare administration and data, earning certification as a certified professional coder (CPC) offers stable career prospects. It emphasizes the importance of understanding medical terminology and coding, which intersects with microbiological concepts in diagnostics and treatment documentation.

Additionally, health information management jobs salary reflect the growing value of professionals who can manage biomedical data efficiently. Graduates with microbiology knowledge can excel here by bridging scientific data with health informatics.

Best Scientists Citing Kent A. Sepkowitz

Trending Scientists

Recently Published Articles